Redeye Orphan Drugs
VirtualAbliva will participate at Redeye's seminar on ‘Drug development in orphan indications.’ CEO Ellen Donnelly will be presenting the company at 10:55 a.m. CEST. Follow link below for further details and live webcast.
Delivering mitochondrial health
Abliva will participate at Redeye's seminar on ‘Drug development in orphan indications.’ CEO Ellen Donnelly will be presenting the company at 10:55 a.m. CEST. Follow link below for further details and live webcast.
CEO Ellen Donnelly will present the company at 1:20 p.m. CEST.